NCT00003551View on ClinicalTrials.gov

Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1998

Study Completion Date

September 30, 2004

Conditions
Kidney Cancer
Interventions
DRUG

aminocamptothecin colloidal dispersion

Trial Locations (2)

30322

Emory University Hospital - Atlanta, Atlanta

Emory University School of Medicine, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER

NCT00003551 - Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer | Biotech Hunter | Biotech Hunter